文献速递血栓与止血

非妊娠成人静脉血栓栓塞干预临床研究结局的识别:范围综述

Identification of outcomes in clinical studies of interventions for venous thromboembolism in non-pregnant adults: A scoping review.
PubMed 文献 · J Thromb Haemost · 2022-06-30

本范围综述检索MEDLINE、Embase和CENTRAL,纳入240篇文献(代表165项前瞻性研究),识别出205个独特结局并归为48个域;91%的研究评估病理生理表现/异常,仅17%评估生活影响、10%评估资源利用,死亡结局见于43%的研究。

要点

  • 共识别205个独特结局,归为48个域,分属死亡、病理生理表现/异常、生活影响和资源利用四大核心领域。
  • 91%的研究评估病理生理表现/异常,43%报告死亡,17%报告生活影响,10%报告资源利用。
  • 仅30项(13%)研究覆盖至少三个核心领域;多数研究侧重病理生理特征,生活影响和资源利用报告较少。

核心结论

  • 大多数静脉血栓栓塞治疗研究评估病理生理特征,但很少报告衡量生活影响或资源利用的结局。
  • 这些发现将为制定静脉血栓栓塞治疗研究核心结局集的后续步骤提供信息。

研究设计与样本

  • 范围综述,检索MEDLINE、Embase和CENTRAL,纳入报告非妊娠成人静脉血栓栓塞干预的前瞻性研究。
  • 研究筛选和数据提取按发表时间分块进行,从2015—2020年开始,随后按1年时间段推进,直至未发现新结局。
  • 共识别7100条记录,纳入240篇出版物,代表165项不同的研究。

主要发现

  • 共识别205个独特结局,归为48个域。
  • 30项(13%)研究覆盖至少三个核心领域。
  • 死亡纳入102项(43%)研究,病理生理表现/异常纳入218项(91%)研究,生活影响纳入41项(17%)研究,资源利用纳入25项(10%)研究。

关键数值与推荐

  • 结局分为域,域分为四个核心领域:死亡、病理生理表现/异常、生活影响和资源利用。
  • 共识别205个独特结局并归为48个域。
  • 覆盖至少三个核心领域的研究为30项(13%)。
  • 死亡纳入102项(43%)研究,病理生理表现/异常纳入218项(91%)研究,生活影响纳入41项(17%)研究,资源利用纳入25项(10%)研究。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The development of a core outcome set (COS), defined as an agreed minimum set of outcome domains that should be measured and reported in all trials of a specific disease, aims to increase the relevance of study findings to stakeholder groups and improve standardization. OBJECTIVES: As the first step in developing a COS for venous thromboembolism (VTE) treatment studies, we aimed to generate an inclusive list of unique outcomes reported in previous VTE treatment studies and classify them into domains and core areas. METHODS: MEDLINE, Embase and CENTRAL were searched for prospective studies reporting on interventions for VTE in non-pregnant adults. Study selection and data extraction were performed in blocks based on publication date, starting with 2015-2020 and subsequent 1-year periods, until no new outcome was identified. Outcomes were classified into domains, which are groups of closely related outcomes, and domains into four core areas including death, pathophysiological manifestations/abnormalities, life impact, and resource use. RESULTS: Of 7100 records identified, 240 publications were included, representing 165 distinct studies. A total of 205 unique outcomes were identified that were grouped into 48 domains; 30 (13%) studies covered at least three core areas; death was included in 102 (43%), pathophysiological manifestations/abnormalities in 218 (91%), life impact in 41 (17%), and resource use in 25 (10%) studies. CONCLUSION: Most VTE treatment studies evaluated pathophysiological features of VTE, but few studies reported outcomes that measured life impact or resource use. The findings will inform next steps in the development of a COS for VTE treatment studies.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Tritschler T, Cusano E, Langlois N, et al. Identification of outcomes in clinical studies of interventions for venous thromboembolism in non-pregnant adults: A scoping review. J Thromb Haemost. 2022. PMID: 35717670. doi:10.1111/jth.15787

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。